MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Environmental exposures and clinical phenotype in a sample of patients with Parkinson’s disease in the southwestern Colombian region: preliminary results

    J. Orozco Velez, H. Clavijo-Moran, D. álvarez-García, I. F Mata, B. Muñoz-Ospina (Cali, Colombia)

    Objective: Describe the clinical phenotype and environmental agents of patients from the Colombian southwestern region with familiar and sporadic Parkinson’s disease in a sample Background:…
  • 2022 International Congress

    Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease

    GBY. Babacan-Yildiz, CZK. Kayacan, IK. Karacan, BS. Sumbul, BE. Elibol, OG. Gelisin, OA. Akgul (ISTANBUL, Turkey)

    Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and  the potential effect of gut microbiota on pre-motor…
  • 2022 International Congress

    IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson’s disease and other neurological conditions

    W. Jost, F. Pagan (Wolfach, Germany)

    Objective: To summarize clinical experience with incobotulinumtoxinA (INCO) for treating chronic sialorrhea due to Parkinson’s disease (PD), atypical parkinsonism, stroke, or traumatic brain injury in…
  • 2022 International Congress

    Glial neurotrophic factor as an early diagnostic marker in Parkinson’s disease

    M. Matmurodov, A. Abduqodirov, L. Khalimova, B. Muminov (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) Background: Glial neutrophic factor (GDNF) is a…
  • 2022 International Congress

    Shared molecular genetic factors influence brain morphometry and Parkinson’s disease risk

    L. Garcia-Marin, P. Reyes, Z. Ceja, N. Ogonowski, B. García-Vilchis, A. Ruiz-Contreras, D. Vazquez-Guevara, S. Alcauter, E. Morelos, A. Medina-Rivera, B. Mitchell, M. Rentería (Brisbane, Australia)

    Objective: To explore the genetic overlap and identify shared genomic regions between brain morphometry and Parkinson’s disease (PD) risk. Background: PD is a genetically complex…
  • 2022 International Congress

    A randomized, double-blinded crossover trial of short versus conventional pulse width subthalamic deep brain stimulation in Parkinson’s Disease

    JN. Petry-Schmelzer, L. Schwarz, H. Jergas, P. Reker, J. Steffen, H. Dafsari, J. Baldermann, G. Fink, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To compare 4 weeks of STN-DBS with conventional pulse width stimulation (60µs) to 4 weeks of STN-DBS with short pulse width stimulation (30µs) regarding…
  • 2022 International Congress

    Effectiveness of Combined tDCS and tNIRS on Motor Performance in Parkinson’s Disease – A Single Case Study

    N. Choudhary (Jodhpur, India)

    Objective: The aim of the current study was to evaluate the synergistic effects of combining transcranial near infrared light stimulation (tNIRS) and transcranial direct current stimulation…
  • 2022 International Congress

    Biomarker based on natural language processing methods to detect the stages of Parkinson’s disease through electroencephalography

    A. Maitin, J. Morales, S. Romero-Azpitarte, J. Romero, A. Arroyo Ferrer, Y. González Zamorano, F. Sánchez Cuesta, A. García-Tejedor (Pozuelo de Alarcón, Spain)

    Objective: Stage classification of Parkinson's Disease (PD) through Electroencephalograms (EEGs) using Natural Language Processing (NLP) techniques. Background: PD is a neurodegenerative disease mainly characterized by…
  • 2022 International Congress

    Analysis of bilateral subthalamic nucleus deep brain stimulation in patients with monogenic forms of Parkinson’s disease: PRKN and LRRK2

    M. Blázquez Estrada, P. Prendes Fernández, E. Suárez Sanmartín, J. Sol Alvarez, C. García Fernández, J. álvarez Carriles, B. Aragoneses, A. Saiz Ayala, E. Santamarta Liébana, M. Alvarez Martínez (Oviedo, Spain)

    Objective: The aim of this study is to compare the clinical and pharmacological response of bilateral STN DBS in patients with monogenic forms of PD…
  • 2022 International Congress

    Longitudinal predictors of functional dependence in a multicentric Parkinson’s Disease cohort

    S. Becker, B. Callahan (Calgary, Canada)

    Objective: To explore clinical and cognitive predictors of functional dependence in a cohort of early Parkinson’s Disease (PD) patients. Background: Parkinson’s Disease (PD) patients are…
  • « Previous Page
  • 1
  • …
  • 318
  • 319
  • 320
  • 321
  • 322
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley